KAYA HOLDINGS INC - KAYS STOCK NEWS

Kaya Holdings, Inc. (KAYS) reported a new partnership with Total Holistic Center to develop a ketamine treatment model. This collaboration marks a significant step toward launching Fifth Dimension Therapeutics Mind Care Clinics and Telehealth Services across Florida. The clinics will initially operate from Total Holistic’s existing locations in Boca Raton, Fort Worth, and Miami Beach, under the direction of Dr. Anya Temer. The treatment aims to address treatment-resistant depression and PTSD. Kaya plans to shift its focus towards domestic psychedelic solutions as it expands its cannabis operations internationally.

Kaya Holdings, Inc. (OTCQB:KAYS) has launched Fifth Dimension Therapeutics (FDT) to provide psychedelic treatments targeting mental health disorders like PTSD and addiction. Bryan Arnold, a senior employee, is pursuing a Psilocybin Facilitator License in Oregon, expected to complete by April. Attorney Glenn E.J. Murphy joins FDT's Board, enhancing connections with pharmaceutical firms and aiding in developing intellectual property and joint ventures. Mental health disorders impose significant economic burdens, with projected costs reaching $6 trillion by 2030. The U.S. psychedelics market is estimated at $2.8 billion, forecasted to reach $8.9 billion by 2029.

Kaya Holdings, Inc. (KAYS) announced plans to obtain licenses for psilocybin manufacturing and facilitation service centers in Oregon, anticipating strong market demand as the global psychedelic therapeutics sector could reach $8-10 billion by 2028. The Oregon Health Authority is expected to start issuing licenses in January 2023. The company, first to operate cannabis licenses across all categories in the U.S., sees this move as a natural extension of its operations. Psilocybin shows promise in treating mental disorders, with market estimates projecting significant growth.

Kaya Holdings (OTCQB: KAYS) announced that its subsidiary, Kaya Farms Greece, received a Cannabis Installation License for its Greek Kaya project in Epidaurus, Greece. This facility will produce KAYS proprietary cannabis brands for EU markets. The project includes 25,000 sq ft for cultivation, a 15,000 sq ft extraction facility, and a 10,000 sq ft packing area, with expansion potential. Management is negotiating a property purchase agreement and highlights the strategic importance of the license for operations in growing cannabis markets in Europe.

Kaya Holdings (OTCQB:KAYS) announced the acquisition of a 50% stake in the Greek Kaya Project, a medical cannabis facility in Epidaurus, Greece, enhancing its footprint in the EU market.

The project features 50,000 square feet of space, including 25,000 square feet for cultivation, a 15,000 square foot EU-GMP extraction facility, and a 10,000 square foot packing area. The facility aims to fast-track KAYS' cannabis products for distribution in various EU markets, awaiting final licensing and project financing.

Kaya Holdings, Inc. (KAYS) has successfully sold its cannabis facility in Eugene, Oregon for $1.325 million. The proceeds will be used to repay debts and bolster the company's balance sheet, enabling further global expansion activities, particularly in Greece and Israel. The planned facilities aim to produce 600,000 pounds of premium cannabis annually for export. This sale will increase cash reserves by approximately $0.09 per share without issuing new shares, decreasing outstanding shares by 6.5%. KAYS remains focused on building a competitive position in the cannabis industry.

Kaya Holdings, Inc. (KAYS) has finalized a settlement with Sunstone Capital Partners concerning the delivery of Oregon Cannabis Production and Processing Licenses. As part of the deal, Bruce Burwick returned 1,006,671 shares to KAYS and received $160,000 from the sale of the facility's grow license. KAYS plans to use the proceeds from selling the property to advance projects in the U.S., Israel, and Greece, aiming to enhance its balance sheet and increase revenues. The company also launched a new logo and website to reflect its global expansion efforts.

Kaya Holdings, Inc. (KAYS) announced participation in the webinar "Cannabis Investment: How Greece is Embracing the Opportunity and Leading the EU Market." CEO Craig Frank highlighted the company's commitment to developing a cannabis cultivation facility in Greece, which, upon obtaining financing and licensing, aims to produce over 85 tonnes of medical-grade cannabis annually for export. The company also operates multiple subsidiaries focused on cannabis retail and product development in the U.S. and plans to expand into international markets, including Greece and Israel.

Kaya Holdings, Inc. (KAYS) announces participation in a May 20, 2021 webinar on cannabis opportunities in Greece, co-hosted by Duane Morris and Greece's Consulate General. The webinar will highlight Greece's potential as a cannabis production hub in the EU. CEO Craig Frank emphasized the company's commitment to developing a cannabis cultivation and processing facility in Greece, projected to produce over 85 tonnes of GMP-certified medical cannabis annually for export, subject to financing and licensing. This initiative represents KAYS's broader international expansion strategy into the cannabis market.